Division of Biotechnologies at ENEA, Italian National Agency for New Technologies, Energy, Environment and Sustainable Economic Development, Via Anguillarese, 301, 00123 Rome, Italy.
Int J Environ Res Public Health. 2024 Aug 2;21(8):1020. doi: 10.3390/ijerph21081020.
In this systematic review, the potential role of in vivo RF-EMF exposure combined with the administration of well-known carcinogens in tumor promotion/progression is assessed. A total of 25 papers were included in the review. Each paper was assessed for Risk of Bias and for the attribution of the quality category. A meta-analysis was conducted on 18 studies, analyzing data for nine different organs/tumors to assess the potential increased risk for the onset of tumors as well as the effects on survival. A descriptive review was performed for the remaining seven eligible papers. In most cases, the results of the meta-analysis did not reveal a statistically significant difference in tumor onset between the sham and co-exposed samples. There was a numerically small increase in the risk of malignant tumors observed in the kidney and liver, as well as benign lung tumors. The level of evidence for health effects indicated "inadequate" evidence for an association between in vivo co-exposure to RF-EMF and known carcinogens and the onset of malignant or benign tumors in most of the analyzed tissues. Nevertheless, the limited number of eligible papers/studies for most of the analyzed tissues suggests that these results cannot be considered definitively conclusive.
在本次系统评价中,评估了体内射频电磁场暴露与已知致癌剂联合作用在肿瘤促进/进展中的潜在作用。共纳入了 25 篇文献。每篇文献均进行了偏倚风险评估,并对质量类别进行归因。对 18 项研究进行了荟萃分析,分析了 9 种不同器官/肿瘤的数据,以评估潜在的肿瘤发病风险增加以及对生存率的影响。对其余 7 篇合格文献进行了描述性综述。在大多数情况下,荟萃分析的结果并未显示假照射和共同暴露样本之间肿瘤发病的统计学显著差异。在肾脏和肝脏以及良性肺肿瘤中,观察到恶性肿瘤风险的数值略有增加。对健康影响的证据水平表明,体内共同暴露于射频电磁场和已知致癌剂与大多数分析组织中恶性或良性肿瘤的发生之间存在“证据不足”的关联。然而,由于大多数分析组织的合格文献/研究数量有限,这些结果不能被认为是确定无疑的结论。